Piper Sandler Reiterates Overweight on Doximity, Raises Price Target to $47
Doximity, Inc. Class A
Doximity, Inc. Class A DOCS | 0.00 |
Piper Sandler analyst Jessica Tassan reiterates Doximity (NYSE:
DOCS) with a Overweight and raises the price target from $42 to $47.
